Published Date: 02 Mar 2023
Head and neck cancer patients whose routine p16 test for HPV is inconclusive should be rescreened with an HPV DNA test, the researchers say.
Read Full NewsAssaf shares insights into how to navigate patient profiles and treatment options to optimize severe asthma care with biologics.
Natalizumab-sztn is an FDA-approved monotherapy for all indications of the reference product natalizumab, including relapsing forms of multiple sclerosis and Crohn disease.
Results from the EVOKE and EVOKE+ phase 3 studies reported that oral semaglutide did not significantly reduce clinical progression in patients with early symptomatic Alzheimer disease.
The FDA has approved Novartis’ intrathecal formulation of onasemnogene abeparvovec-brve, marketed as Itvisma, for patients ages 2 years and older living with spinal muscular atrophy.
Findings revealed that vitamin D deficiency was associated with an increased risk of NMOSD in East Asian populations, whereas the effect of smoking among Caucasians and other populations was inconsistent.
Doug Kerr, MD, PhD, chief medical officer at Dyne Therapeutics, discusses the clinical development of DYNE-101 for myotonic dystrophy type 1 and DYNE-251 for Duchenne muscular dystrophy.
This Fall Clinical Dermatology Conference interview features Peter Lio, MD, discussing takeaways from several of his sessions at the meeting.
1.
Scientists call into question safety of potential new anticancer treatment
2.
Alternative breast imaging techniques beyond mammography.
3.
Skinny melanoma incidence is associated with vitamin D deficiency.
4.
Good News for CAR-T Therapy; Liquid Biopsy Progress; Anti-Psychotic for Brain Cancer
5.
The lack of psychiatrists may be addressed by community workers.
1.
The Science Behind Imatinib: How It Targets Cancer Cells
2.
Unlocking the Mystery of Methaemoglobinaemia: A New Hope for Treatment
3.
Exploring the Latest Advances in Hodgkin's Lymphoma Treatment
4.
Exploring The Causes and Consequences of Low Transferrin Saturation
5.
What is Red Cell Distribution Width and Why Should You Care?
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
3.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
5.
Navigating the Complexities of Ph Negative ALL - Part V
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation